Exogenous nerve growth factor (NGF) improves the cholinergic neuron system and has therapeutic potential for neurodegenerative disorders such as Parkinson’s disease, Alzheimer’s disease, and diabetic polyneuropathy. Here, NGF is linked to diabetic polyneuropathy.